Table 2 Type of treatment (n = 97)

Current type of treatment

97 (100)

 TKI

64 (66.0)

 ICI

19 (19.6)

 ICI + ICI

7 (7.2)

 ICI + TKI

3 (3.1)

 mTOR + TKI

4 (4.1)

Line of treatment

101 (100)

 First-line

47 (46.5)

 Second-line

20 (19.8)

 Third-line

16 (15.8)

 Three + 

18 (17.8)

Drugs used

 Axitinib

7 (7.2)

 Cabozantinib

18 (18.6)

 Avelumab + Axitinib

2 (2.1)

 Everolimus + Lenvatinib

4 (4.1)

 Nivolumab + Ipilimumab

7 (7.2)

 Pemrolizumab + Axitinib

1 (1.0)

 Lenvatinib (Kisplyx)

3 (3.1)

 Nivolumab (Opdivo)

19 (19.6)

 Pazopanib (Votrient)

13 (13.4)

 Sorafenib (Nexavar)

1 (1.0)

 Sunitinib (Sutent)

22 (22.7)